Skip to main content

Home›Legal›GHK-Cu in New York

Educational — Not Legal AdviceUpdated

GHK-Cu in New York: Legal Status & Provider Guide (2026)

Quick Answer

GHK-Cu is available without a prescription in some forms in the United States. GHK-Cu is not FDA-approved. Topical applications are available without prescription. Injectable formulations are compounded under physician oversight. Its status as a naturally occurring peptide distinguishes it from fully synthetic research compounds. In New York, compounding is governed by the New York State Board of Pharmacy (NYSBP). New York requires a collaborative practice agreement for nurse practitioners prescribing controlled substances, but NPs with full prescriptive authority may prescribe most compounded peptides independently. Physician assistants require physician supervision for prescribing. New York's telehealth prescribing rules require prescribers to hold a New York license; interstate telemedicine prescribing is tightly regulated.

Federal Legal Status

FDA Approval Status

GHK-Cu is not FDA-approved as a drug. It is a naturally occurring copper-binding peptide present in human plasma. In cosmetic formulations, it is used without prescription. Injectable or prescription GHK-Cu requires a physician's order and compounding pharmacy.

Compounding Pharmacy Rules (Federal)

GHK-Cu can be compounded by 503A pharmacies under a valid prescription. It is not on the FDA 503A or 503B bulk substances lists as a designated substance, but it is a naturally occurring peptide (not a synthetic novel compound), which has historically resulted in more permissive treatment by some pharmacy boards. Cosmetic (topical) applications are widely available without a prescription.

Also Known As

Copper Peptide GHK-Cu · Glycyl-L-histidyl-L-lysine copper · GHK

Primary Research Areas

  • Wound healing
  • Skin repair
  • Hair growth
  • Anti-inflammatory effects
  • Anti-aging

New York Pharmacy Board & Compounding Rules

Compounding Overview

New York has among the most stringent pharmacy and prescribing regulations in the country. The New York State Board of Pharmacy enforces USP 797 and 795 standards and requires all compounding pharmacies to meet detailed quality and documentation requirements. New York has been particularly active in enforcing against unapproved compounded medications. In-state telehealth peptide providers are subject to strict New York Medical Board oversight.

Notable Rules

  • New York requires compounding pharmacies to register separately for sterile compounding.
  • The New York Department of Health has enforcement authority over unlicensed pharmaceutical activity.
  • New York has stricter-than-federal requirements for documentation of medical necessity for compounded preparations.
  • Interstate prescribing into New York requires a New York state license.
  • New York and Pennsylvania maintain reciprocal pharmacy licensure recognition for some categories.

Prescribing Requirements in New York

New York requires a collaborative practice agreement for nurse practitioners prescribing controlled substances, but NPs with full prescriptive authority may prescribe most compounded peptides independently. Physician assistants require physician supervision for prescribing. New York's telehealth prescribing rules require prescribers to hold a New York license; interstate telemedicine prescribing is tightly regulated.

About GHK-Cu

GHK-Cu (glycyl-L-histidyl-L-lysine copper) is a naturally occurring tripeptide that binds copper ions. It is found in human plasma, saliva, and urine, declining with age. Research has focused on skin repair, anti-inflammatory effects, and potential neuroprotective properties.

For more research information, mechanism of action, and provider availability, see the GHK-Cu research profile on PeptideBase.

Frequently Asked Questions

Is GHK-Cu available without a prescription?
Topical GHK-Cu (creams, serums) is widely available without a prescription. Injectable or infused GHK-Cu requires a physician's prescription and compounding pharmacy. The topical form is regulated as a cosmetic, not a drug.

GHK-Cu Providers in New York

5 providers in the PeptideBase directory offer GHK-Cu in New York. Always verify current offerings directly with the provider.

View all GHK-Cu providers nationwide →

GHK-Cu Legal Status in Other States

Pharmacy board rules and compounding regulations vary by state. Compare GHK-Cu legal status across other major markets:

PeptideBase provides educational research tools and provider discovery. It does not provide medical advice, diagnosis, treatment, prescribing guidance, or dosing instructions. Consult a qualified healthcare professional before making health decisions.

Content review: This educational overview is prepared by the PeptideBase editorial team and reviewed for factual accuracy. Reviewer byline coming soon (gated on 4.4). Last updated: .

Free newsletter

The Peptide Research Digest

Weekly analysis on providers, sourcing and compounds — from the team behind PeptideBase.

No spam. Unsubscribe anytime. Privacy policy.

Free Guide

The Peptide Research Digest

Get our free provider vetting guide — plus weekly research briefings on peptide sourcing, COA verification, and clinical developments.

No spam.